Clinical Trials Logo

Filter by:
NCT ID: NCT06450392 Not yet recruiting - Orbital Edema Clinical Trials

The Effect of Local and Systemic Tranexamic Acid on Edema and Ecchymosis in Orbital Surgery

Start date: July 2024
Phase: Phase 4
Study type: Interventional

Tranexamic acid is a synthetic reversible competitive inhibitor to plasminogen lysine receptor, which prevents plasmin formation and stabilizes the fibrin matrix, thus reducing bleeding. While recent studies have demonstrated the antifibrinolytic benefits of TXA in obstetric and gynecologic conditions, traumatic hemorrhage, cardiac surgery, total knee arthroplasty, and more, there is a paucity of clinical data on TXA use in plastic surgery. The aim of this study is to evaluate the effect of local and systemic TXA on postoperative periocular ecchymosis/edema in orbital surgery.

NCT ID: NCT06450353 Recruiting - Clinical trials for Allogeneic Transplantation

Prospective Evaluation of Disparities in Provision of Allogeneic Transplantation

Start date: May 31, 2024
Phase:
Study type: Observational

To look at the effect of a recipient's ancestry and socio-economic status on their choice of bone marrow transplantation donor cells and their chance of receiving genetically similar (allogeneic) bone marrow cells versus cells that are not genetically similar (allograft).

NCT ID: NCT06450197 Not yet recruiting - Clinical trials for Moderate to Severe Crohn's Disease

Phase IIa Study Evaluating AZD7798 in Crohn's Disease

AMALTHEA
Start date: June 17, 2024
Phase: Phase 2
Study type: Interventional

This is a randomised, double-blind, parallel group, placebo-controlled Phase IIa study designed to evaluate the efficacy and safety of AZD7798 in participants with moderate to severe Crohn's disease.

NCT ID: NCT06450171 Not yet recruiting - Clinical trials for Predisposition, Genetic

Evaluation of Multi-Cancer Early Detection Testing in a High-Risk Population: The INFORM Study

Start date: December 2024
Phase: N/A
Study type: Interventional

The purpose of this research study is to evaluate the possible benefits and harms of screening with an investigational blood test designed to detect many types of cancer early. The name of the screening blood test being studied is: -GRAIL Galleri test

NCT ID: NCT06450158 Recruiting - Cerebral Palsy Clinical Trials

Robot-assisted Training in Children With CP

Start date: September 25, 2021
Phase: N/A
Study type: Interventional

Cerebral palsy (CP) is the most common physical disability in early childhood causing serious motor and sensory impairments. Effective interventions for the recovery of motor functions are of profound significance to children with CP, their families, caregivers, and health professionals. Robot-assisted rehabilitation represents a frontier with potential to improve motor functions and induce brain reorganization in children with CP.

NCT ID: NCT06450041 Not yet recruiting - Neuroblastoma Clinical Trials

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

Start date: July 2024
Phase: Phase 2
Study type: Interventional

This is a phase II study looking at patient response to treatment with the combination dinutuximab, temozolomide, irinotecan, and GM-CSF.

NCT ID: NCT06449872 Completed - Clinical trials for Obstetric Complication

OB-GYN Clinical Validation Study

Start date: October 24, 2023
Phase: N/A
Study type: Interventional

This is a single-site study evaluating obstetrics and gynecology exam imaging quality by expert users.

NCT ID: NCT06449638 Not yet recruiting - Diabetic Foot Clinical Trials

Modified Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of Hard-to-Heal DFUs

CAMPSTIM
Start date: June 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the efficacy of four dehydrated complete human placental membrane, also defined as Cellular, Acellular, Matrix-like Products/skin substitutes, plus SOC versus SOC alone in achieving complete closure of hard-to-heal diabetic foot ulcers over 12 weeks using a modified platform trial design.

NCT ID: NCT06449365 Completed - Sedation Clinical Trials

Comparison of Intravenous V/S Nasal Atomizer Delivery of Midazolam for Conscious Sedation for No-scalpel Vasectomy

Start date: October 22, 2017
Phase: Phase 4
Study type: Interventional

Purpose: This study compared administration of midazolam via intravenous route with nasal atomizer route for moderate sedation in an office-based vasectomy clinic.

NCT ID: NCT06449352 Recruiting - Clinical trials for Normal Tension Glaucoma

Effect of Netarsudil vs Brimonidine in NTG Patients on Latanoprost

Start date: June 30, 2024
Phase: Phase 4
Study type: Interventional

A randomized, multicenter, investigator-masked prospective study of NTG patients currently on latanoprost 0.005% monotherapy, to study the effect of IOP change with the introduction of netarsudil 0.02% vs brimonidine 0.1%. Subjects will be assessed at a screening visit, and 1 follow-up visit. Clinical evaluations will include visual acuity and IOP .